Neogen (NEOG) EBITDA Margin (2010 - 2026)
Neogen (NEOG) recorded EBITDA Margin of 12.48% in fiscal Q1 2027 (quarter ended Aug 31, 2026), up 6.02 percentage points from 6.45% a year earlier but down 2.17 percentage points from the prior quarter.
Neogen (NEOG) EBITDA Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Neogen's EBITDA Margin came in at 12.55% as of Aug 31, 2026, up 120.53 percentage points year-over-year; for FY2026 (ended May 31, 2026), it came in at 11.11%, up 115.98 percentage points from FY2025.
- Annual EBITDA Margin has a five-year change of -9.21 percentage points (FY2021 to FY2026).
- Across earlier fiscal years, EBITDA Margin came in at -104.87% in FY2025 (-124.21 pp), 19.34% in FY2024 (+3.70 pp), 15.64% in FY2023 (+0.02 pp) and 15.61% in FY2022 (-4.71 pp).
- Quarterly EBITDA Margin has ranged from -257.34% in fiscal Q4 2025 to 21.80% in fiscal Q4 2023 over the past five years.
- On a year-over-year basis, EBITDA Margin rose in three of the last eight quarters, with an average year-over-year change of -2.64 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 271.99 percentage points in fiscal Q4 2026, against a drop of 275.35 percentage points in fiscal Q4 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at 14.65% (Q4 2026), 12.36% (Q3 2026) and 10.69% (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 253.69 Bn | 232.72 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 174.31 Bn | 144.74 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 164.52 Bn | 148.33 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 153.84 Bn | 133.27 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 120.45 Bn | 85.71 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 116.37 Bn | 102.49 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 66.13 Bn | 60.90 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 53.84 Bn | 50.99 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 51.32 Bn | 35.32 Bn | 1.35 Bn | 31.93% |
| 10 | Neogen | 2.63 Bn | 1.97 Bn | 105.50 Mn | 12.48% |
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 12.48% |
| May 31, 2026 | 14.65% |
| Feb 28, 2026 | 12.36% |
| Nov 30, 2025 | 10.69% |
| Aug 31, 2025 | 6.45% |
| May 31, 2025 | -257.34% |
| Feb 28, 2025 | 16.12% |
| Nov 30, 2024 | -184.46% |
| Aug 31, 2024 | 15.17% |
| May 31, 2024 | 18.01% |
| Feb 29, 2024 | 18.59% |
| Nov 30, 2023 | 19.51% |
| Aug 31, 2023 | 21.28% |
| May 31, 2023 | 21.80% |
| Feb 28, 2023 | 20.17% |
| Nov 30, 2022 | 8.73% |
| Aug 31, 2022 | 8.91% |
| May 31, 2022 | 17.05% |
| Feb 28, 2022 | 9.90% |
| Nov 30, 2021 | 14.02% |
Neogen EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NEOG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NEOG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NEOG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();